Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy - Tian, Meng-Xin; Zhou, Yu-Fu; Qu, Wei-Feng; Liu, Wei-Ren; Jin, Lei; Jiang, Xi-Fei; Wang, Han; Tao, Chen-Yang; Zhou, Pei-Yun; Fang, Yuan; Ding, Zhen-Bin; Peng, Yuan-Fei; et al. (Cancer Immunology, Immunotherapy, 2019)
Keywords: Antigens, Tumor-Associated, Carbohydrate - metabolism; Atrophy; Biomarkers, Tumor - metabolism; Cancer Research; Cholangiocarcinoma; Cholangiocarcinoma - diagnosis; Cholangiocarcinoma - mortality; Cholangiocarcinoma - pathology; Cohort Studies; Female; gamma-Glutamyltransferase - metabolism; Hepatectomy; Histopathology; Humans; Immunohistochemistry; Immunology; Liver - metabolism; Liver - pathology; Liver Neoplasms - diagnosis; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Male; Malignancy; Medical prognosis; Medicine; Medicine & Public Health; Metastases; Middle Aged; Multivariate analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oncology; Original; Original Article; Prognosis; Research Design; Risk factors; Risk groups; Survival Analysis; Tumor Burden; γ-Glutamyltransferase; Recurrence; Prognosis; Immunoscore; Intrahepatic cholangiocarcinoma